Asthma drug could halve chance of developing Parkinson’s

News

Author: Parkinson's Life editorsPublished: 28 September 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Asthma medication

A recent study has found that a drug most commonly used for asthma may cut the chances of developing Parkinson’s.

The research, carried out by Harvard Medical School, Massachusetts, US, found that those who inhaled salbutamol – a drug found in inhalers – were half as likely to develop the condition.

In Parkinson’s disease, a protein named a-synuclein accumulates in various brain cells and can be fatal. To counter this, the research team grew human nerve cells and tested over 1000 medications, finding results to suggest salbutamol could cut the production of a-synuclein.

Neurologist Anthony Lang, who works at the University of Toronto, Canada, said the results were “fascinating” and “had come out of the blue”.

Despite some encouraging developments, Clemens Scherzer, who was a part of the research team, said clinical trials were “a few years off”.

Go Back

Share this story

Comments


Related articles


Parkinson's UK first Excellence Network awards

Global update

John Stapleton: “More Parkinson’s research is needed, full stop”

#UniteForParkinsons: the broadcaster shares his experiences

READ MORE
Sue Wylie Kinetics

Interviews

I hope my Parkinson’s play changes the way doctors deal with diagnosis

How my diagnosis inspired me to write a play about Parkinson’s

READ MORE
Parkinson's UK audit 2015 lead

PD in Practice

Over 1/3 of patients don’t receive enough info about Parkinson’s at diagnosis

Parkinson’s UK outlines key areas for improvement in care in audit

READ MORE